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Over the last 20 years, endocrine disruption
research has shown how chemicals in our
environment can profoundly affect develop-
ment, growth, maturation, and reproduction
by mimicking hormones or interacting with
hormone receptors. One important mecha-
nism of endocrine disruption is altered gene
expression, mediated by inappropriate activa-
tion or deactivation of receptors that act as
transcription factors. 
Yet, receptor-mediated changes in gene
expression are just the tip of the iceberg.
There are many more mechanisms of gene
regulation that are potentially susceptible to
alteration by environmental influences. The
effect of environmental contaminants on
health is a major concern because exposure is
associated with a number of diseases, includ-
ing cancer, diabetes, and infertility. 
The purpose of this review is to identify
points of gene expression regulation, occur-
ring along the process described by the cen-
tral dogma (DNA → RNA → protein), that
have been shown to be affected by environ-
mental factors, particularly contaminants
(Figure 1). We have drawn on research that
shows a strong connection between environ-
mentally induced changes in gene regulatory
mechanisms and disease etiology (Figure 1). 
Pesticides, Gene Translocation,
and Non-Hodgkin Lymphoma
A number of cancers, including childhood
leukemia and follicular non-Hodgkin lym-
phoma (NHL), are characterized by specific
translocations (Smith et al. 2005; Tsujimoto
et al. 1985) promoted by physical proximity
of the affected genes within the nucleus
[reviewed by Verschure (2004)]. In follicular
NHL, the anti-apoptotic B-cell leukemia/
lymphoma 2 (bcl-2) gene, normally found on
chromosome 18, translocates to the immuno-
globulin heavy chain locus on chromo-
some 14 (Roulland et al. 2004; Tsujimoto
et al. 1985). This t(14;18) translocation places
bcl-2 under the control of the heavy chain
enhancer, resulting in the overexpression of
bcl-2 and, consequently, increased cell survival
and lymphomagenesis [reviewed by Roulland
et al. (2004)]. 
The t(14;18) translocation occurs in the
lymphocytes of healthy people and those with
follicular NHL, and not all people with follicu-
lar NHL possess the translocation (Baccarelli
et al. 2006; Roulland et al. 2004). Nonetheless,
increased frequency of the translocation is a
marker for increased lymphoma risk (Schroeder
et al. 2001). Epidemiologic evidence indicates a
positive association between t(14;18)-positive
NHL and exposure to a variety of pesticides,
including dieldrin, toxaphene, lindane,
atrazine, and fungicides (Schroeder et al. 2001).
Roulland et al. (2004) show that occupational
exposure to pesticides can increase the fre-
quency of the t(14;18) translocation, both in
terms of the number of people affected, and the
number of affected lymphocytes within those
people. Exposure to 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD) is also correlated
with increased number of circulating t(14;18)
positive lymphocytes (Baccarelli et al. 2006). It
appears that t(14;18) translocation frequency
depends on how often pesticide exposure
occurs, such that NHL risk increases with
ongoing accumulation of genetic instability,
acquired as a result of pesticide exposure
(Roulland et al. 2004). Thus, variability in
environmental exposure, coupled with genetic
events like translocation, alters disease risk.
Environmental Factors, DNA
Methylation, and Fetal Origins
of Adult Disease
A growing number of animal studies show
that parental diet and other exposures can
inﬂuence fetal DNA methylation patterns and
permanently affect health outcomes in later
life (Dolinoy et al. 2006; Wu G et al. 2004;
Yu et al. 1999). Moreover, there is evidence
that environmentally induced changes in
DNA methylation patterns are heritable across
generations (Anway et al. 2005; Newbold
et al. 1998, 2000; Ruden et al. 2005; Turusov
et al. 1992; Walker and Haven 1997). To
understand how and when environmental fac-
tors might change DNA methylation, why
these changes are potentially heritable, and
how they can contribute to the fetal origins of
adult disease, it is helpful to consider examples
in the context of ontogeny.
Ontogeny of DNA methylation and envi-
ronmental inﬂuence. DNA methylation occurs
in two modes: dynamic methylation and theo-
retically permanent methylation, such as X
chromosome inactivation and genomic
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[Online 21 May 2007]imprinting (Bestor 2000). In dynamic
methylation, DNA methylation/demethyla-
tion reactions turn genes on or off throughout
the life of an organism (Cervoni and Szyf
2001). For example, Wilks et al. (1984)
showed active demethylation of the vitel-
logenin promoter in response to estradiol
treatment in chickens. The more permanent,
although not irreversible, methylation patterns
are determined during early embryogenesis
(Guerrero-Bosagna et al. 2005; Hajkova et al.
2002; Reik et al. 2001; Tan et al. 1993; Wu G
et al. 2004) and continue to adjust through
the neonatal period (Day et al. 2002; Weaver
et al. 2004). 
Figure 2 shows a developmental timeline
for the establishment of methylation patterns.
During gametogenesis, each parent resets
most but not all the imprints and methylation
patterns in his or her germ cells (Reik et al.
2001). This ensures that the parent passes on
an imprinted pattern that exclusively reﬂects
his or her own sex. Between fertilization and
implantation, the embryo demethylates most
of its genes, with the exception of imprinted
and some repeat genes (Reik and Walter
2001; Reik et al. 2001; Surani 2001). The
maintenance of imprinted genes through the
preimplantation period is essential for normal
embryonic development (Surani 2001; Wu Q
et al. 2004). However, demethylation of other
genes is important for making the genome
broadly available to the undifferentiated and
developing embryo. In addition, demethyla-
tion in the embryo may help to remove epi-
genetic modifications acquired during
parental gametogenesis. Between cleavage and
gastrulation, remethylation occurs throughout
the embryo. X chromosome inactivation
occurs over the period between implantation
and organogenesis (Tan et al. 1993). At gas-
trulation, the primordial germ cells (PGCs)
are newly formed and exhibit methylation
similar to the surrounding somatic cells
(Hajkova et al. 2002). Some germ cells also
exhibit X inactivation (Tam et al. 1994).
During PGC proliferation and migration, X
inactivation is completed (Tam et al. 1994).
However, when the germ cells enter the geni-
tal ridge, their DNA undergoes global
demethylation, including loss of parental
imprints, and reactivation of the inactive X
(Hajkova et al. 2002; Reik et al. 2001; Reik
and Walter 2001; Surani 2001; Tam et al.
1994). Whether demethylation affects all
genes is under debate. Remethylation and
imprinting then occur in a sex-speciﬁc man-
ner during gametogenesis (Reik et al. 2001).
After birth, somatic cell methylation patterns
continue to adjust, based on developmental
and environmental factors (Weaver et al.
2004, 2005). As an individual ages, there is a
gradual loss or gain of methylation, depend-
ing on the cell, tissue, or organ (Ehrlich 2002;
Richardson 2003). 
Even before conception, organisms are vul-
nerable to environmentally altered methylation.
This phenomenon has been observed in mice
exposed preconceptionally to chromium (III)
chloride, a carcinogen found in welding fumes.
The 10-week-old offspring of male mice treated
with chromium 2 weeks before conception
exhibit signiﬁcant increases in serum cortico-
sterone and glucose concentrations (Cheng
et al. 2002), as well as increased tumor risk
and frequency of developmental abnormali-
ties, relative to controls (Yu et al. 1999).
Observed tumors or anomalies include
pheochromocytomas, thyroid follicular cell
and Harderian gland tumors, ovarian cysts,
uterine abnormalities, lung tumors (female
offspring only), reproductive gland tumors
(male offspring only), and renal nonneoplas-
tic lesions (male offspring only). These effects
result, in part, from chromium-induced epi-
genetic changes in the sperm that alter
parental imprinting. Speciﬁcally, the sperm of
chromium-treated mice exhibit a significant
increase in the number of undermethylated
copies of the 45S ribosomal RNA gene
(rRNA) (Cheng et al. 2004; Shiao et al.
2005). 45S rRNA is the precursor of other
rRNAs that are part of the ribosome machin-
ery and a control point for the number of
ribosomes in a cell. Increased ribosome num-
ber and associated deregulation of protein
synthesis could be one step in the progression
toward tissue growth, proliferation, and ulti-
mately malignancy (Ruggero and Pandolfi
2003; Shiao et al. 2005). 
After conception, between cleavage and
gastrulation, the timing and pattern of
remethylation is also subject to environmental
inﬂuence. Amino acid deﬁciency, for example,
causes a marked decrease in overall DNA
methylation, along with abnormal expression
of the normally silent, paternally imprinted
and growth-related H19 allele in cultured
mouse embryos (Doherty et al. 2000).
Conversely, Wu Q et al. (2004) showed
increased methylation of the H19/insulin-like
growth factor 2 (Igf2) imprint control region,
increased methyltransferase activity, and
decreased fetal growth after transfer to a recipi-
ent dam following in vitro exposure of mouse
embryos to TCDD from the one-cell stage to
the blastocyst stage. TCDD is a widespread
and persistent environmental contaminant
that is formed during the production of paper,
polyvinyl chloride (PVC) plastics and chlori-
nated pesticides, and during the incineration
of chlorine-containing products. Human
exposure to TCDD is primarily dietary
(Centers for Disease Control and Prevention
2005). Aberrant H19/Igf2 imprinting and
expression are associated with development of
a number of tumors, including Wilms tumor
(Taniguchi et al. 1995), testicular germ cell
tumors (Vangurp et al. 1994), ovarian tumors
(Kim et al. 1998), and adrenocortical tumors
(Gao et al. 2002). Furthermore, alterations in
fetal growth related to H19/Igf2 imprinting
are associated with metabolic disorders in
adulthood, including obesity and diabetes
(Smith et al. 2006). 
In addition to H19/Igf2 imprinting pat-
terns, other genes that predispose for obesity
can be affected by maternal diet. Dolinoy et al.
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Figure 1. Summary of gene regulatory mechanisms affected by environmental exposures, with disease
implications. Abbreviations: BPA, bisphenol A; NP, 4-nonylphenol; PAHs, polycyclic aromatic hydrocarbons,
PCBs, polychlorinated biphenlys; OP, 4-tert-octylphenol.
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Parental care(2006) observed that dietary genistein (the
major phytoestrogen in soy) during gestation
in mice increased methylation of a retrotrans-
poson located upstream of the Agouti gene,
effectively reducing expression of the gene.
Agouti transcription causes yellow fur, obesity,
and tumorigenesis. Thus, Agouti expression in
the unexposed offspring predisposed them to
obesity later in life. In addition, only 7% of the
genistein-supplemented mice were yellow,
compared with 21% of the unsupplemented
animals. The degree of DNA methylation was
similar in endodermal, mesodermal, and ecto-
dermal tissues, suggesting genistein acts during
early embryonic development.
After birth, somatic cell methylation pat-
terns continue to adjust to developmental and
environmental factors. Li et al. (1997) showed
that neonatal exposure to the synthetic estro-
gen diethylstilbestrol (DES) caused abnormal
demethylation of the CpG sites upstream of
the estrogen-response element of the lactoferrin
promoter. Lactoferrin is an important estrogen-
inducible glycoprotein component of uterine
secretions and is a useful marker of estrogen
responsivity (Pentecost and Teng 1987). In
another study, Weaver et al. (2004) showed
that increased licking, grooming, and arched-
back nursing behavior of rat mothers reduced
methylation of the glucocorticoid receptor
(GR) promoter region in the hippocampus.
Thus, rats that experienced high-quality (vs.
low-quality) maternal behavior exhibited
increased GR expression, greater glucocorticoid
feedback sensitivity, and a better response to
stress later in life (lower plasma corticosterone
concentrations after 20 min of restraint stress).
The epigenetic alteration was noticeable in the
ﬁrst week after birth and persisted into adult-
hood. The effect could be reversed with cross-
fostering, showing it to be a consequence of
maternal behavior rather than gestation or
genetic inheritance. Furthermore, the effect of
high-quality maternal care on GR demethyla-
tion and reduced stress response could be
reversed in adulthood with a central infusion
of the methyl donor L-methionine (Weaver
et al. 2005). These studies by Weaver et al.
(2004, 2005) emphasize the potential for
DNA methylation patterns to respond to envi-
ronmental inﬂuences throughout life. 
Finally, as an individual ages, there is a
gradual loss or gain of methylation, depend-
ing on the tissue, cell, or organ. The interac-
tion between aberrant methylation and age is
recognized as a possible early step in carcino-
genesis [reviewed by Richardson (2003)].
This is especially true of oncogenes or tumor
suppressor genes that become incorrectly
demethylated or methylated, respectively
(Ehrlich 2002). In some cases these changes
may be mediated by improperly regulated
DNA methyltransferase (Dnmt) enzymes.
Gastric cancer cells are often characterized by
overexpression of Dnmt1 with hypermethyla-
tion of genes relevant to the etiology of gastric
cancer, including human MutL homologue 1
(hMLH1), thrombospondin-1 (THBS-1), and
E-cadherin (Etoh et al. 2004). This pattern is
associated with Epstein-Barr virus infection,
which potentially stimulates Dnmt1 over-
expression (Etoh et al. 2004). In other cases,
altered methylation of oncogenes or tumor
suppressor genes is mediated by dietary folate
intake. Folate, found in fresh fruits and
vegetables, is needed to make S-adenosyl-
methionine, the primary methyl donor for
methylation (Kraunz et al. 2006). Folate deﬁ-
ciency is associated with hypermethylation of
the p16INK4A (CDKN2A) gene in human head
and neck squamous cell carcinoma (HNSCC)
and a rat model of hepatocellular carcinoma
(Kraunz et al. 2006; Pogribny et al. 2004). In
HNSCC, degree of p16INK4A silencing is also
modified by functional polymorphisms in
methylene tetrahydrofolate reductase, an
enzyme that regulates serum folate levels
(Kraunz et al. 2006). 
Inheritance of methylation patterns.
Inheritance of methylation patterns is of great
interest because it provides a mechanism by
which a parent’s acquired alterations in
methylation could be passed to offspring.
Anway et al. (2005) showed that gestational
exposure of male rats to vinclozolin (anti-
androgenic fungicide) or methoxychlor (estro-
genic organochlorine insecticide) during the
time of gonadal sex determination caused
decreased sperm count and viability and
increased rates of infertility in adulthood.
This loss of fertility was perpetuated through
the male germ line for four generations and
occurred in conjunction with altered, herita-
ble methylation patterns. 
Inheritance of altered methylation patterns
could explain the transgenerational effects of
DES exposure. DES is a synthetic estrogen
given to pregnant women between 1938 and
Edwards and Myers
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Figure 2. Ontogenetic timeline of methylation in mammals. PGCs, primordial germ cells. From parental
gametogenesis, through fertilization, embryonic and neonatal development, and aging, the genome experi-
ences stages of methylation and demethylation. Asymmetry of methylation is sometimes observed
between maternal and paternal genomes, between somatic and germ cells, and among different tissues.
Environmental factors have been shown to influence methylation patterns at multiple points in develop-
ment. Please see “Ontogeny of DNA methylation and environmental inﬂuence” for details.
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In the zygote, enhancement of
imprinting asymmetry between
parental genomes occurs; paternal
genome undergoes demethylation,
whereas maternal genome undergoes
de novo methylation (Surani 2001).
Global demethylation of most genes,
except imprinted and some repeat
genes (Reik et al. 2001; Surani 2001).
Remethylation of somatic and germ
cells; timing and pattern depends on
species, tissue lineage, intrauterine
environment and maternal nutrition
(Guerrero-Bosagna et al. 2005;
Hajkova et al. 2002; Reik et al. 2001;
Wu G et al. 2004).
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fed a genistein diet (Day et al. 2002).
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carcinogenesis [reviewed by
Richardson (2003)].
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At gastrulation, embryonic germ cells
exhibit methylation and prental
imprinting patterns (Hakova et al. 2002).
During proliferation and migration of
PGCs, X inactivation is completed
(Tam et al. 1994). When PGCs reach the
genital ridge, they are characterized
by global demethylation, including loss
of parental imprints; repetitive
elements exhibit more protracted or
incomplete demethylation (Hajkova
et al. 2002; Reik et al. 2001; Surani 2001).
Reactivation of the inactive X occurs
before meiosis (Tam et al. 1994).
Remethylation and imprinting of germ
cells in sex-specific manner takes
place during gametogenesis
(Reik et al. 2001).1971 to prevent miscarriages. The children and
grandchildren of humans and mice exposed to
DES in utero exhibit increased rates of uterine
sarcomas and adenocarcinomas, lymphomas,
malignant reproductive tract tumors in both
males and females, proliferative lesions of
the rete testis, and benign ovarian tumors
(Newbold et al. 1998, 2000; Turusov et al.
1992; Walker and Haven 1997). Li et al.
(2003) showed that DES exposure alters
methylation patterns associated with the pro-
moters of many estrogen-responsive genes that
regulate reproductive organ development in
both mice and humans. In addition, Ruden
et al. (2005) recently published a novel
hypothesis suggesting that the transgenera-
tional effects of DES are associated with
altered DNA methylation, possibly mediated
through modiﬁed WNT signaling.
Cadmium, DNA Repair,
and Diabetes
In 2003 Schwartz et al. (2003) published a
large cross-sectional human study in which
they reported a signiﬁcant positive relationship
between urinary cadmium, impaired fasting
glucose, and diabetes, suggesting that cadmium
exposure plays a role in diabetes etiology.
Using monkeys, Kurata et al. (2003) showed
that cadmium accumulates in the pancreas and
that chronic exposure initiates degeneration of
islet β cells and induces the clinical signs of
diabetes. Cadmium exposure also potentiates
some diabetic complications related to renal
tubular and glomerular function (Akesson
et al. 2005). 
Cadmium-induced diabetes may be a side
effect of enhanced DNA repair. A variety of
genotoxic environmental factors, including
cadmium and several pesticides, cause DNA
strand breaks or fragmentation (Bolognesi
2003; Palus et al. 2003; Yang et al. 2003).
Poly (ADP-ribose) polymerase-1 (PARP-1)
recognizes the strand breaks and promotes
break repair by loosening chromatin structure
[Benjamin and Gill (1980); reviewed by
Rouleau et al. (2004)]. Specifically, PARP-1
catalyzes histone ribosylation—the addition of
ADP-ribose molecules to histone lysine
residues. The resulting negative charge to the
histones causes electrostatic repulsion away
from the negatively charged DNA, making it
more accessible to repair enzymes (Virág and
Szabó 2002). Following DNA repair, the
ADP-ribose is freed, becoming briefly avail-
able for the stable glycation of other histones
and proteins (Cervantes-Laurean et al. 1996;
Diefenbach and Bürkle 2005). This mimics
glycation caused by hyperglycemia (Gugliucci
and Bendayan 1995) and could explain why
chronic cadmium exposure induces clinical
signs of diabetes. 
In addition, sugar-modified histones can
undergo other transformations [described by
Cervantes-Laurean et al. (1996)] to form
advanced glycosylation end products (AGEs).
AGE accumulation associated with histones
and other proteins is implicated in the progres-
sion of aging and age related diseases like dia-
betes and Alzheimer disease (Cervantes-Laurean
et al. 1996; Gugliucci and Bendayan 1995). 
Air Pollution, Activation of
Inﬂammatory Genes, and
Respiratory Disease
Respiratory diseases such as chronic obstruc-
tive pulmonary disease, cystic fibrosis, inter-
stitial lung disease, acute respiratory distress
syndrome, and asthma are characterized by
expression of inﬂammation genes, which can
be activated or intensiﬁed by exposure to air
pollution. 
Air pollution consists of tiny ambient par-
ticles measuring < 10–15 µm in diameter
(PM10) that come from dust, smoke, or
aerosol liquids produced by vehicles, factories,
construction sites, plowed fields, or burning
wood. Air pollution can include residual oil
ﬂy ash (ROFA), an inorganic mixture of sili-
cates and metal salts containing vanadium,
zinc, iron, and nickel released during the
combustion of low-grade oil (Henry and
Knapp 1980; Samet et al. 2002). 
In vitro studies with human airway epithe-
lial cells show that exposure to diesel soot and
other PM10 particles activates pro-inﬂamma-
tory genes in a process mediated by free radi-
cal/oxidative stress mechanisms (Boland et al.
2000; Donaldson et al. 2003; Gilmour et al.
2001, 2003; Marano et al. 2002). The oxida-
tive stress induces pro-inﬂammation transcrip-
tion factors such as nuclear factor κB (NF-κB)
and activator protein 1 (AP-1) (Donaldson
et al. 2003), which in turn promote increased
histone acetyltransferase (HAT) activity, his-
tone acetylation, interleukin-8 (IL-8) protein
release (IL-8 is a marker of inﬂammation), and
finally, expression of inflammatory genes
(Gilmour et al. 2001, 2003).
ROFA exposure stimulates a similar cascade
of events. Using a perfused rabbit lung model,
Samet et al. (2002) showed that the vanadium
component of ROFA can inhibit tyrosine phos-
phatases, causing phosphorylation of NF-κB
and other proinﬂammation transcription fac-
tors, including activating transcription factor 2
(ATF-2), c-Jun, and cAMP response element
binding–protein (CREB). Again, this leads to
expression of inﬂammatory genes, potentially
exacerbating respiratory distress.
Environmental Estrogens,
Transcription, and Allergies
Bisphenol A (BPA) is a synthetic estrogen that
was investigated for use in birth control pills
but was instead favored as a plasticizer for use
in polycarbonate plastics, dental sealants, and
the lining of food cans. Both BPA and
4-nonylphenol (NP), a derived product of
nonionic surfactants, have been shown to acti-
vate estrogen receptor alpha (ER-α), induce
estrogen-dependent gene expression, and
stimulate growth in estrogen responsive MCF7
breast cancer cells (Vivacqua et al. 2003). 
The effects of these chemicals are not lim-
ited to classical estrogen signaling. Lee et al.
(2003, 2004) showed that BPA, NP, and
4-tert-octylphenol (OP), used widely in deter-
gents and wetting agents, increased the T-cell
allergic response, measured as an increase in
interleukin-4 (IL-4) mRNA levels, in antigen-
stimulated mouse T cells. The IL-4 promoter
in mice and humans contains multiple bind-
ing sites for a transcription factor called
nuclear factor of activated T cells (NF-AT)
(Lee et al. 2004). It appears that BPA, OP,
and NP enhance IL-4 production by stimulat-
ing the calcium-dependent calcineurin signal-
ing pathway. This causes dephosphorylation
of cytoplasmic NF-AT with subsequent
translocation of the transcription factor to the
nucleus. Lee et al. (2003, 2004) suggest that
increased NF-AT concentrations in the
nucleus up-regulate IL-4 transcription, caus-
ing the T-cell allergic response observed with
BPA, NP, or OP exposure. 
Environmental Factors,
RNA Stability, and Tumor
Development or Reproductive
Dysfunction
TCDD is a persistent and widespread environ-
mental contaminant that is a potent car-
cinogen in rodents and a suspected human
carcinogen with multiple modes of action.
One way that TCDD promotes carcinogenesis
is by stabilizing the mRNA of urokinase plas-
minogen activator (uPA), a serine protease that
contributes to matrix turnover and growth of
tumor cells (Gaido and Maness 1995; Shimba
et al. 2000). High uPA mRNA concentrations
are found in tumors such as hepatocellular car-
cinoma but not in healthy tissues, and simi-
larly, survival time is inversely related to uPA
mRNA concentrations (De Petro et al. 1998).
In rat liver cells, the TCDD-induced stabiliza-
tion of uPA mRNA is mediated by a 50-kDa
cytoplasmic protein (p50) that binds speciﬁ-
cally to sites in the 3´ untranslated region of
uPA mRNA (Shimba et al. 2000). Shimba
et al. (2000) showed that p50 is activated
rapidly (in 15 min) by TCDD-mediated phos-
phorylation. They suggest that p50 stabilizes
uPA mRNA by protecting nuclease cleavage
sites from attack. 
In a second TCDD study, Minegishi et al.
(2003) showed that TCDD exposure reduced
the half-life of luteinizing hormone receptor
(LH-R) mRNA in rat granulosa cells. This
could impact steroidogenesis, luteinization,
and ovulation by reducing granulosa cell sensi-
tivity to circulating LH. The authors speculate
Gene-by-environment interactions and disease
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regulatory proteins that destabilize LH-R
mRNA. For example, TCDD may facilitate
the binding of appropriate proteins to the AU
(adenylate/uridylate)-rich elements (AREs) of
LH-R, thus promoting degradation of the
mRNA by exosomes. 
In addition to uPA, several other proteases
are important in tumor development. Among
these are the matrix metalloproteinases
(MMPs), which promote tumor invasion.
Bao et al. (2006) showed that vitamin D (1α,
25-dihydroxyvitamin D3) reduced the mRNA
stability of metalloproteinase 9 (MMP-9) in a
human prostate cancer cell line. This, along
with other actions of vitamin D, inhibited the
invasive ability of the cancer cells. 
The role of vitamin D in the prevention of
prostate cancer could be applicable in other
situations as well. For example, Ritchie et al.
(2003) reported that long-term, low-dose
exposure to polychlorinated biphenyls (PCBs)
could contribute to an increased risk of
prostate cancer in the general human popula-
tion. PCBs are no longer manufactured in the
United States, but even after several decades of
banning, PCBs remain a persistent environ-
mental contaminant that people encounter
mostly through their diet (Ritchie et al. 2005).
Given the study by Bao et al. (2006), which
suggests that vitamin D has anti-prostate can-
cer properties, it is interesting to note that
PCBs have been shown to reduce serum vita-
min D concentrations in rat dams and their
offspring (Lilienthal et al. 2000). It is worth
testing if PCBs increase cancer risk via changes
in vitamin D metabolism or efficacy with
regard to processes like reduced MMP-9
mRNA stability. 
Pesticides, Impaired Protein
Degradation, and Parkinson
Disease
Parkinson disease (PD) is a neurodegenerative
disease that affects more than 1 million people
in the United States alone (Sun et al. 2005). It
is diagnosed by the presence of intracyto-
plasmic inclusions in dopaminergic neurons.
These inclusions, known as “Lewy bodies,” are
composed primarily of α-synuclein protein
aggregates (Baba et al. 1998). Lewy body for-
mation also characterizes some forms of demen-
tia and Alzheimer disease (Tu et al. 1998). 
PD can occur in families or sporadically and
is associated with both genetic and environmen-
tal causes (Moore et al. 2005). A familial form
of PD involves genomic triplication and conse-
quent overexpression of the α-synuclein gene
(Singleton et al. 2003). In both familial and spo-
radic forms of PD, the timely degradation of
α-synuclein is inhibited in part by proteasome
dysfunction (Mytilineou et al. 2004), an effect
that appears to be exacerbated by α-synuclein
overexpression (Sun et al. 2005). 
Using an immortalized rat mesencephalic
dopaminergic cell line (N27 cells) transfected
with the human α-synuclein gene, Sun et al.
(2005) showed that exposure to 30 µM dieldrin
(an organochlorine pesticide) impaired protea-
some function, resulting in a marked increase in
α-synuclein positive aggregates. This dose was
deduced by the authors to represent the
expected human exposure level after 50 years;
dieldrin is lipophilic and bioaccumulates signiﬁ-
cantly in the central nervous system (Fleming
et al. 1994). In addition, when α-synuclein was
overexpressed the dieldrin worked additively
with the protein to impair proteasome function
and trigger neuronal apoptosis. Sun et al.
(2005) argue that exposure to neurotoxic chem-
icals such as dieldrin increases risk for PD, par-
ticularly among individuals predisposed to
α-synuclein accumulation for genetic or age-
related reasons. Other pesticides, including the
herbicide paraquat the fungicide maneb and the
insecticide rotenone, are causally linked to
α-synuclein accumulation and dopaminergic
cell degeneration and apoptosis [reviewed by
Meredith et al. (2004)]. Rotenone is so effective
that it is used to generate a rodent model for
PD (Betarbet et al. 2000).
Pharmaceuticals, Gene
Ampliﬁcation/Mutation, 
and Drug Resistance
When faced with death, cells adapt individu-
ally and as a population. For example, in
Escherichia coli, starvation of lac– bacteria on
lactose medium induces lac+ revertants. The
revertants exhibit either gene amplification
(20- to 100-fold) of the lac– allele, or a com-
pensatory frameshift mutation that randomly
produces the lac+ allele in association with
wide-spread, stress-induced, hypermutation
(Cairns and Foster 1991; Hastings et al. 2004;
Hersh et al. 2004). Ampliﬁcation of the lac–
allele (increased gene copy number) eases the
starvation stimulus because the allele is leaky,
conferring 1–2% of the wild-type β-galactosi-
dase activity (Foster 1994). The revertants are
apparently produced de novo in response to
starvation because they appear more rapidly
and at higher frequencies than would be pre-
dicted by selection-only models [reviewed by
Hersh et al. (2004)]. Hence, the phenomenon
is termed “adaptive ampliﬁcation/mutation.”
E. coli provide empirical evidence for the
ability of cells to enhance their survival in
response to environmental pressures through
genomic plasticity and adaptation. A major dif-
ficulty that affects cancer therapy is the pro-
gressive development of drug resistance
observed in a subset of patients. As in the
E. coli example, tumor cells can respond to
treatment by amplifying and/or mutating
genes that promote their survival. For example,
androgen deprivation is a common therapy for
prostate cancer. However, some patients
respond well initially to the therapy, but then
slowly develop resistance resulting in improved
tumor growth (Koivisto et al. 1997). Koivisto
et al. (1997) report that this pattern is associ-
ated with progressive amplification of the
androgen receptor (AR) gene along with sub-
stantially increased AR mRNA expression. 
A related observation was made by Copur
et al. (1995), who showed that continuous
exposure of cultured human colon cancer cells
to the colon cancer drug 5-ﬂuorouracil (5-FU),
causes thymidylate synthase (TS) gene ampliﬁ-
cation and overexpression of the TS protein.
Overexpression of TS conferred 5-FU resis-
tance and provides an explanation for the
development of fluoropyrimidine chemo-
therapy resistance among patients with colon
cancer (Copur et al. 1995).
In the context of these studies, is it possible
that exposure to environmental contaminants
could initiate adaptive amplification/
mutation? In 1989, Prody et al. (1989) pub-
lished a suggestive but isolated study in which
they reported de novo 100-fold ampliﬁcation 
of the silent serum butyrylcholinesterase
(BtChoEase) gene in a farmer exposed chroni-
cally to organophosphate insecticides, which
inhibit BtChoEase. The silent BtChoEase gene
codes for a defective protein that makes
homozygous individuals particularly sensitive
to organophosphate poisoning. The ampliﬁca-
tion was not present in the man’s parents but
was inherited by his son, indicating that germ
cells were also affected. 
Insecticides, alternative RNA splicing, 
and pesticide resistance. Not all forms of resis-
tance result from gene amplification or
compensatory mutation. Glutathione S-trans-
ferases (GSTs) make up a family of multifunc-
tion enzymes that play an important role in
detoxification of xenobiotic compounds
(Jirajaroenrat et al. 2001). GSTs contribute to
insecticide resistance among insects, including
mosquitoes (Brown 1986), and to multidrug
resistance in tumor cell lines and cancer patients
(Hayes and Pulford 1995). In Anopheles mos-
quitoes, one of the GST genes, adgst1AS1,
codes for (at least) four RNA splice variants that
vary in their binding characteristics with regard
to permethrin, a pyrethroid insecticide
(Jirajaroenrat et al. 2001). Alternative RNA
splicing could explain the rapid increase in per-
methrin resistance, associated with GST upregu-
lation, observed among Culex mosquitoes
selected for just one or three generations (Xu
et al. 2005). It is not known if pyrethroid expo-
sure causes changes in GST activity in humans.
Environmental Contaminants,
Transposons, and
Carcinogenesis
Transposon derived sequences account for at
least 45% of the human genome, a hefty pro-
portion when compared with the 1% given
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2003). They are of great medical interest for
two reasons. First, LINE-1 (L1) retrotrans-
posons, along with the 412 retrotransposon in
Drosophila and the VL30 retrotransposons in
mice and humans, are activated in the normal
course of gonad and gamete development, and
in fact, may play a regulatory role in these
processes (Brookman et al. 1992; Schiff et al.
1991; Trelogan and Martin 1995). Second,
retrotransposons and reverse transcriptase (RT)
are activated in the tumors of several different
cancers [reviewed by Sinibaldi-Vallebona et al.
(2006)]. Sinibaldi-Vallebona et al. (2006)
report that drug-mediated inhibition of RT
activity or silencing of L1 retrotransposons by
RNA interference (RNAi) reduces cell growth
and stimulates differentiation of cancer cell
lines. These observations suggest an active role
for retrotransposons in carcinogenesis that
could be related to their original developmen-
tal role becoming misregulated later in life. 
Further, a small amount of evidence sug-
gests that transposons can be activated by envi-
ronmental contaminants. Transposon activation
has been observed in HeLa cells (human cervical
cancer cell line) and vascular smooth muscle
cells of mice and humans exposed in vitro to the
carcinogen benzo[a]pyrene (Lu et al. 2000; Lu
and Ramos 1998; Stribinskis and Ramos 2006)
and in the livers of male mummichogs (ﬁsh)
exposed to pyrene, a common PAH found
ubiquitously in the environment and at several
estuarine Superfund sites in the United States
(Roling et al. 2004). El-Sawy et al. (2005)
reported that nickel activates L1 retrotransposi-
tion in transfected HeLa cells. In addition,
Morales et al. (2002) showed that serum,
testosterone, dihydrotestosterone, and a mix-
ture of 17 organochlorine pesticides stimulated
transcription of the L1Hs retrotransposon pro-
moter in human choriocarcinoma cells. These
examples support the hypothesis that environ-
mentally induced transposon activity could be
important in the etiology of cancer and possibly
other diseases. 
Conclusions
The studies reviewed in this article show how
environmental factors inﬂuence a diverse array
of molecular mechanisms and consequently
alter disease risk. They emphasize the plasticity
of the genome and its regulation, providing
support for genomic reaction and adaptation
in response to environmental stimuli. Further,
they provide direct evidence that chemicals
placed in the environment by human activity
can and do promote disease by altering gene
expression. Epigenetic studies in particular
provide insights that further our understand-
ing of fetal origins of adult disease, while also
offering new research avenues for the investi-
gation of acquired, and potentially heritable,
genetic variation and disease susceptibility. 
In terms of environmental contamination,
these studies show that attention to onto-
genetic processes, genetic background, devel-
opmental stage, timing and duration of
exposure, and the interactions associated with
mixtures is critical to quality risk assessment.
Further, they address why a given chemical
can have multiple modes of action and why
sensitivity to chemical exposure varies among
individuals. Most important, these studies
indicate new ways of thinking about disease
etiology, showing that disease risk is best pre-
dicted by considering genetic and environ-
mental factors in tandem. 
REFERENCES
Akesson AA, Lundh T, Vahter M, Bjellerup P, Lidfeldt J,
Nerbrand C, et al. 2005. Tubular and glomerular kidney
effects in Swedish women with low environmental cad-
mium exposure. Environ Health Perspect 113:1627–1631.
Anway MD, Cupp AS, Uzumcu M, Skinner MK. 2005. Epigenetic
transgenerational actions of endocrine disruptors and
mate fertility. Science 308(5727):1466–1469.
Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, et al.
1998. Aggregation of α-synuclein in Lewy bodies of spo-
radic Parkinson’s disease and dementia with Lewy bodies.
Am J Pathol 152(4):879–884.
Baccarelli A, Hirt C, Pesatori AC, Consonni D, Patterson DG,
Bertazzi PA, Dolken G, Landi MT. 2006. t(14;18) transloca-
tions in lymphocytes of healthy dioxin-exposed individuals
from Seveso, Italy. Carcinogenesis 27(10):2001–2007.
Bao BY, Yeh SD, Lee YF. 2006. 1 α,25-dihydroxyvitamin D-3
inhibits prostate cancer cell invasion via modulation of
selective proteases. Carcinogenesis 27(1):32–42. 
Benjamin RC, Gill DM. 1980. Poly(ADP-ribose) synthesis in vitro
programmed by damaged DNA—a comparison of DNA
molecules containing different types of strand breaks.
J Biol Chem 255(21):502–508.
Bestor TH. 2000. The DNA methyltransferases of mammals.
Hum Mol Genet 9(16):2395–2402.
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov
AV, Greenamyre JT. 2000. Chronic systemic pesticide
exposure reproduces features of Parkinson’s disease. Nat
Neurosci 3(12):1301–1306.
Boland S, Bonvallot V, Fournier T, Baeza-Squiban A, Aubier M,
Marano F. 2000. Mechanisms of GM-CSF increase by
diesel exhaust particles in human airway epithelial cells.
Am J Physiol Lung Cell Mol Physiol 278(1):L25–L32.
Bolognesi C. 2003. Genotoxicity of pesticides: a review of
human biomonitoring studies. Mutat Res 543(3):251–272.
Brookman JJ, Toosy AT, Shashidhara LS, White RAH. 1992. The
412 retrotransposon and the development of gonadal meso-
derm in Drosophila. Development 116(4):1185–1192.
Brown AWA. 1986. Insecticide resistance in mosquitoes—a
pragmatic review. J Am Mosq Control Assoc 2(2):123–140.
Cairns J, Foster PL. 1991. Adaptive reversion of a frameshift
mutation in Escherichia coli. Genetics 128(4):695–701.
Centers for Disease Control and Prevention. 2005. Third National
Report on Human Exposure to Environmental Chemicals.
National Center for Environmental Health Publ no 05-0570.
Atlanta:Centers for Disease Control and Prevention.
Cervantes-Laurean D, Jacobson EL, Jacobson MK. 1996.
Glycation and glycoxidation of histones by ADP-ribose.
J Biol Chem 271(18):10461–10469.
Cervoni N, Szyf M. 2001. Demethylase activity is directed by
histone acetylation. J Biol Chem 276(44):40778–40787.
Cheng RYS, Alvord WG, Powell D, Kasprzak KS, Anderson LM. 2002.
Increased serum corticosterone and glucose in offspring of
chromium(III)-treated male mice. Environ Health Perspect
110:801–804.
Cheng RYS, Hockman T, Crawford E, Anderson LM, Shiao YH. 2004.
Epigenetic and gene expression changes related to trans-
generational carcinogenesis. Mol Carcinog 40(1): 1–11.
Copur S, Aiba K, Drake JC, Allegra CJ, Chu E. 1995. Thymidylate
synthase gene amplification in human colon cancer cell
lines resistant to 5-ﬂuorouracil. Biochem Pharmacol 49(10):
1419–1426.
Day JK, Bauer AM, desBordes C, Zhuang Y, Kim BE, Newton LG,
et al. 2002. Genistein alters methylation patterns in mice.
J Nutr 132(8):2419S–2423S.
De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S.
1998. Expression of urokinase-type plasminogen activator
(uPA), uPA receptor, and tissue-type PA messenger RNAs in
human hepatocellular carcinoma. Cancer Res 58(10):
2234–2239.
Diefenbach J, Bürkle A. 2005. Introduction to poly(ADP-ribose)
metabolism. Cell Mol Life Sci 62(7–8):721–730.
Doherty AS, Mann MRW, Tremblay KD, Bartolomei MS, Schultz
RM. 2000. Differential effects of culture on imprinted H19
expression in the preimplantation mouse embryo. Biol
Reprod 62(6):1526–1535.
Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. 2006. Maternal
genistein alters coat color and protects A(vy) mouse off-
spring from obesity by modifying the fetal epigenome.
Environ Health Perspect 114:567–572.
Donaldson K, Stone V, Borm PJA, Jimenez LA, Gilmour PS,
Schins RPF, et al. 2003. Oxidative stress and calcium signal-
ing in the adverse effects of environmental particles (PM10).
Free Radic Biol Med 34(11):1369–1382.
Ehrlich M. 2002. DNA methylation in cancer: too much, but also
too little. Oncogene 21(35):5400–5413.
El-Sawy M, Kale SP, Dugan C, Nguyen TQ, Belancio V, Bruch
H, et al. 2005. Nickel stimulates L1 retrotransposition by a
post-transcriptional mechanism. J Mol Biol 354(2):246–257.
Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M,
et al. 2004. Increased DNA methyltransferase 1 (DNMT1)
protein expression correlates signiﬁcantly with poorer tumor
differentiation and frequent DNA hypermethylation of multiple
CpG islands in gastric cancers. Am J Pathol 164(2):689–699.
Fleming L, Mann JB, Bean J, Briggle T, Sanchezramos JR. 1994.
Parkinson’s disease and brain levels of organochlorine pes-
ticides. Ann Neurol 36(1):100–103.
Foster PL. 1994. Population dynamics of a lac(–) strain of
Escherichia coli during selection for lactose utilization.
Genetics 138(2):253–261.
Gaido KW, Maness SC. 1995. Posttranscriptional stabilization of
urokinase plasminogen-activator messenger RNA by 2,3,7,8-
tetrachlorodibenzo-p-dioxin in a human keratinocyte cell
line. Toxicol Appl Pharmacol 133(1):34–42.
Gao ZH, Suppola S, Liu J, Heikkila P, Janne J, Voutilainen R. 2002.
Association of H19 promoter methylation with the expres-
sion of H19 and IGF-II genes in adrenocortical tumors. J Clin
Endocrinol Metab 87(3):1170–1176.
Gilmour PS, Rahman I, Donaldson K, MacNee W. 2003. Histone
acetylation regulates epithelial IL-8 release mediated by
oxidative stress from environmental particles. Am J Physiol
Lung Cell Mol Physiol 284(3):L533–L540.
Gilmour PS, Rahman I, Hayashi S, Hogg JC, Donaldson K,
MacNee W. 2001. Adenoviral E1A primes alveolar epithelial
cells to PM10-induced transcription of interleukin-8. Am J
Physiol Lung Cell Mol Physiol 281(3):L598–L606.
Guerrero-Bosagna C, Sabat P, Valladares L. 2005. Environmental
signaling and evolutionary change: can exposure of preg-
nant mammals to environmental estrogens lead to epigeneti-
cally induced evolutionary changes in embryos? Evol Dev
7(4):341–350.
Gugliucci A, Bendayan M. 1995. Histones from diabetic rats con-
tain increased levels of advanced glycation end products.
Biochem Biophys Res Commun 212(1):56–62.
Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, et al.
2002. Epigenetic reprogramming in mouse primordial germ
cells. Mech Dev 117(1–2):15–23.
Hastings PJ, Slack A, Petrosino JF, Rosenberg SM. 2004. Adaptive
ampliﬁcation and point mutation are independent mecha-
nisms: evidence for various stress-inducible mutation
mechanisms. PLOS Biol 2(12):2220–2233.
Hayes JD, Pulford DJ. 1995. The glutathione S-transferase super-
gene family: Regulation of GST and the contribution of the
isoenzymes to cancer chemoprotection and drug resistance.
Crit Rev Biochem Mol Biol 30(6):445–600.
Henry WM, Knapp KT. 1980. Compound forms of fossil fuel ﬂy-ash
emissions. Environ Sci Technol 14(4):450–456.
Hersh MN, Ponder RG, Hastings PJ, Rosenberg SM. 2004.
Adaptive mutation and ampliﬁcation in Escherichia coli: two
pathways of genome adaptation under stress. Res Microbiol
155(5):352–359.
Jirajaroenrat K, Pongjaroenkit S, Krittanai C, Prapanthadara LA,
Ketterman AJ. 2001. Heterologous expression and charac-
terization of alternatively spliced glutathione S-transferases
from a single Anopheles gene. Insect Biochem Mol Biol
31(9):867–875.
Jordan IK, Rogozin IB, Glazko GV, Koonin EV. 2003. Origin of a
Gene-by-environment interactions and disease
Environmental Health Perspectives • VOLUME 115 | NUMBER 9 | September 2007 1269Edwards and Myers
1270 VOLUME 115 | NUMBER 9 | September 2007 • Environmental Health Perspectives
substantial fraction of human regulatory sequences from
transposable elements. Trends Genet 19(2):68–72.
Kim HT, Choi BH, Niikawa N, Lee TS, Chang SI. 1998. Frequent
loss of imprinting of the H19 and IGF-II genes in ovarian
tumors. Am J Med Genet 80(4):391–395.
Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola
J, et al. 1997. Androgen receptor gene ampliﬁcation: A possi-
ble molecular mechanism for androgen deprivation therapy
failure in prostate cancer. Cancer Res 57(2):314–319.
Kraunz KS, Hsiung D, McClean MD, Liu M, Osanyingbemi J,
Nelson HH, Kelsey KT. 2006. Dietary folate is associated with
p16INK4A methylation in head and neck squamous cell carci-
noma. Int J Cancer 119(7):1553–1557.
Kurata Y, Katsuta O, Doi T, Kawasuso T, Hiratsuka H, Tsuchitani
M, et al. 2003. Chronic cadmium treatment induces islet B
cell injury in ovariectomized Cynomolgus monkeys. Jpn J
Vet Res 50(4):175–183.
Lee MH, Chung SW, Kang BY, Park J, Lee CH, Hwang SY, et al.
2003. Enhanced interleukin-4 production in CD4(+) T cells
and elevated immunoglobulin E levels in antigen-primed
mice by bisphenol A and nonylphenol, endocrine disruptors:
involvement of nuclear factor-AT and Ca2+. Immunology
109(1):76–86.
Lee MH, Kim E, Kim TS. 2004. Exposure to 4-tert-octylphenol, an
environmentally persistent alkylphenol, enhances inter-
leukin-4 production in T cells via NF-AT activation. Toxicol
Appl Pharmacol 197(1):19–28.
Li SF, Hursting SD, Davis BJ, McLachlan JA, Barrett JC. 2003.
Environmental exposure, DNA methylation, and gene regula-
tion—lessons from diethylstilbesterol-induced cancers. In:
Epigenetics in Cancer Prevention: Early Detection and Risk
Assessment. New York:New York Academy of Sciences,
161–169.
Li SF, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, et al.
1997. Developmental exposure to diethylstilbestrol elicits
demethylation of estrogen-responsive lactoferrin gene in
mouse uterus. Cancer Res 57(19):4356–4359.
Lilienthal H, Fastabend A, Hany J, Kaya H, Roth-Harer A,
Dunemann L, et al. 2000. Reduced levels of 1,25-dihydroxy-
vitamin D-3 in rat dams and offspring after exposure to a
reconstituted PCB mixture. Toxicol Sci 57(2):292–301.
Lu KP, Hallberg LH, Tomlinson J, Ramos KS. 2000. Benzo(a)pyrene
activates L1Md retrotransposon and inhibits DNA repair in
vascular smooth muscle cells. Mutat Res 454(1–2):35–44.
Lu KP, Ramos KS. 1998. Identification of genes differentially
expressed in vascular smooth muscle cells following
benzo[a]pyrene challenge: implications for chemical athero-
genesis. Biochem Biophys Res Commun 253(3):828–833.
Marano F, Boland S, Bonvallot V, Baulig A, Baeza-Squiban A.
2002. Human airway epithelial cells in culture for studying
the molecular mechanisms of the inflammatory response
triggered by diesel exhaust particles. Cell Biol Toxicol
18(5):315–320.
Meredith GE, Halliday GM, Totterdell S. 2004. A critical review of
the development and importance of proteinaceous aggre-
gates in animal models of Parkinson’s disease: new insights
into Lewy body formation. Parkinsonism Relat Disord
10(4):191–202.
Minegishi T, Hirakawa T, Abe K, Kishi H, Miyamoto K. 2003. Effect
of IGF-1 and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on
the expression of LH receptors during cell differentiation in
cultured granulosa cells. Mol Cell Endocrinol 202(1–2):
123–131.
Moore DJ, West AB, Dawson VL, Dawson TM. 2005. Molecular
pathophysiology of Parkinson’s disease. Annu Rev Neurosci
28:57–87.
Morales JF, Snow ET, Murnane JP. 2002. Environmental factors
affecting transcription of the human L1 retrotransposon. I.
Steroid hormone-like agents. Mutagenesis 17(3):193–200.
Mytilineou C, McNaught KSP, Shashidharan P, Yabut J, Baptiste
RJ, Parnandi A, et al. 2004. Inhibition of proteasome activity
sensitizes dopamine neurons to protein alterations and
oxidative stress. J Neural Transm 111(10–11):1237–1251.
Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J,
McLachlan JA. 1998. Increased tumors but uncompromised
fertility in the female descendants of mice exposed develop-
mentally to diethylstilbestrol. Carcinogenesis 19(9):1655–1663.
Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J,
McLachlan JA. 2000. Proliferative lesions and reproductive
tract tumors in male descendants of mice exposed develop-
mentally to diethylstilbestrol. Carcinogenesis 21(7):1355–1363.
Palus J, Rydzynski K, Dziubaltowska E, Wyszynska K, Natarajan
AT, Nilsson R. 2003. Genotoxic effects of occupational expo-
sure to lead and cadmium. Mutat Res Genet Toxicol Environ.
Mutagen. 540(1):19–28.
Pentecost BT, Teng CT. 1987. Lactotransferrin is the major estro-
gen inducible protein of mouse uterine secretions. J Biol
Chem 262(21):10134–10139.
Pogribny IP, James SJ, Jernigan S, Pogribna M. 2004. Genomic
hypomethylation is specific for preneoplastic liver in
folate/methyl deﬁcient rats and does not occur in non-target
tissues. Mutat Res 548: 53–9.
Prody CA, Dreyfus P, Zamir R, Zakut H, Soreq H. 1989. De novo
ampliﬁcation within a silent human cholinesterase gene in a
family subjected to prolonged exposure to organophospho-
rous insecticides. Proc Natl Acad Sci USA 86(2):690–694.
Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in
mammalian development. Science 293(5532):1089–1093.
Reik W, Walter J. 2001. Genomic imprinting: parental inﬂuence on
the genome. Nat Rev Genet 2(1):21–32.
Richardson B. 2003. Impact of aging on DNA methylation. Ageing
Res Rev 2(3):245–261.
Ritchie JM, Vial SL, Fuortes LJ, Guo HJ, Reedy VE, Smith EM.
2003. Organochlorines and risk of prostate cancer. J Occup
Environ Med 45(7):692–702.
Ritchie JM, Vial SL, Fuortes LJ, Robertson LW, Guo HJ, Reedy VE,
et al. 2005. Comparison of proposed frameworks for group-
ing polychlorinated biphenyl congener data applied to a
case-control pilot study of prostate cancer. Environ Res
98(1):104–113.
Roling JA, Bain LJ, Baldwin WS. 2004. Differential gene expres-
sion in mummichogs (Fundulus heteroclitus) following treat-
ment with pyrene: comparison to a creosote contaminated
site. Mar Environ Res 57(5):377–395.
Rouleau M, Aubin RA, Poirier GG. 2004. Poly(ADP-ribosyl)ated
chromatin domains: access granted. J Cell Sci 117(6):815–825.
Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon
P. 2004. Characterization of the t(14;18) BCL2-IGH trans-
location in farmers occupationally exposed to pesticides.
Cancer Res 64(6):2264–2269.
Ruden DM, Xiao L, Garﬁnkel MD, Lu X. 2005. HSP90 and environ-
mental impacts on epigenetic states: a model for the trans-
generational effects of diethylstilbestrol on uterine
development and cancer. Hum Mol Genet 14:R149–R155.
Ruggero D, Pandolﬁ PP. 2003. Does the ribosome translate can-
cer? Nat Rev Cancer 3(3):179–192.
Samet JM, Silbajoris R, Huang T, Jaspers I. 2002. Transcription
factor activation following exposure of an intact lung prepa-
ration to metallic particulate matter. Environ Health Perspect
110:985–990.
Schiff R, Itin A, Keshet E. 1991. Transcriptional activation of
mouse retrotransposons in vivo—specific expression in
steroidogenic cells in response to trophic hormones. Genes
Dev 5(4):521–532.
Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount
B, et al. 2001. Agricultural risk factors for t(14;18) subtypes of
non-Hodgkin’s lymphoma. Epidemiology 12(6):701–709.
Schwartz GG, Il’yasova D, Ivanova A. 2003. Urinary cadmium,
impaired fasting glucose, and diabetes in the NHANES III.
Diabetes Care 26(2):468–470.
Shiao YH, Crawford EB, Anderson LM, Patel P, Ko K. 2005. Allele-
speciﬁc germ cell epimutation in the spacer promoter of the
45S ribosomal RNA gene after Cr(III) exposure. Toxicol Appl
Pharmacol 205(3):290–296.
Shimba S, Hayashi M, Sone H, Yonemoto J, Tezuka M. 2000.
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces binding
of a 50 kDa protein on the 3 ‘ untranslated region of uro-
kinase-type plasminogen activator mRNA. Biochem Biophys
Res Commun 272(2):441–448.
Singleton AB, Farrer M, Johnson J, Singleton A, Hague S,
Kachergus J, et al. 2003. α-Synuclein locus triplication
causes Parkinson’s disease. Science 302(5646):841–841.
Sinibaldi-Vallebona P, Lavia P, Garaci E, Spadafora C. 2006. A
role for endogenous reverse transcriptase in tumorigene-
sis and as a target in differentiating cancer therapy. Genes
Chromosomes Cancer 45(1):1–10.
Smith FM, Garﬁeld AS, Ward A. 2006. Regulation of growth and
metabolism by imprinted genes. Cytogenet Genome Res
113(1–4):279–291.
Smith MT, McHale CM, Wiemels JL, Zhang LP, Wiencke JK,
Zheng SC, et al. 2005. Molecular biomarkers for the study of
childhood leukemia. Toxicol Appl Pharmacol 206(2):237–245.
Stribinskis V, Ramos KS. 2006. Activation of human long inter-
spersed nuclear element 1 retrotransposition by benzo(a)-
pyrene, a ubiquitous environmental carcinogen. Cancer Res
66(5):2616–2620.
Sun F, Anantharam V, Latchoumycandane C, Kanthasamy A,
Kanthasamy AG. 2005. Dieldrin induces ubiquitin-proteasome
dysfunction in α-synuclein overexpressing dopaminergic
neuronal cells and enhances susceptibility to apoptotic cell
death. J Pharmacol Exp Ther 315(1):69–79.
Surani MA. 2001. Reprogramming of genome function through
epigenetic inheritance. Nature 414(6859):122–128.
Tam PPL, Zhou SX, Tan SS. 1994. X-Chromosome activity of the
mouse primordial germ cells revealed by the expression of an
X-linked LacZ transgene. Development 120(10):2925–2932.
Tan SS, Williams EA, Tam PPL. 1993. X-chromosome inactivation
occurs at different times in different tissues of the post-
implantation mouse embryo. Nature Genet 3(2):170–174.
Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE. 1995. Epigenetic
changes encompassing the Igf2/H19 locus associated with
relaxation of Igf2 imprinting and silencing of H19 in Wilms
tumor. Proc Natl Acad Sci USA 92(6):2159–2163.
Trelogan SA, Martin SL. 1995. Tightly regulated, developmentally
specific expression of the first open reading frame from
Line-1 during mouse embryogenesis. Proc Natl Acad Sci
USA 92(5):1520–1524.
Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. 1985. The
T(14,18) chromosome translocations involved in B-cell neo-
plasms result from mistakes in VDJ joining. Science 229(4720):
1390–1392.
Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, et al.
1998. Glial cytoplasmic inclusions in white matter oligoden-
drocytes of multiple system atrophy brains contain insoluble
α-synuclein. Ann Neurol 44(3):415–422.
Turusov VS, Trukhanova LS, Parfenov YD, Tomatis L. 1992.
Occurrence of tumors in the descendants of CBA male mice
prenatally treated with diethylstilbestrol. Int J Cancer 50(1):
131–135.
Vangurp R, Oosterhuis JW, Kalscheuer V, Mariman ECM,
Looijenga LHJ. 1994. Biallelic expression of the H19 and Igf2
genes in human testicular germ cell tumors. J Natl Cancer
Inst 86(14):1070–1075.
Verschure PJ. 2004. Positioning the genome within the nucleus.
Biol Cell 96(8):569–577.
Virág L, Szabó C. 2002. The therapeutic potential of poly (ADP-
ribose) polymerase inhibitors. Pharmacol Rev 54(3):375–429.
Vivacqua A, Recchia AG, Fasanella G, Gabriele S, Carpino A,
Rago V, et al. 2003. The food contaminants bisphenol A and
4-nonylphenol act as agonists for estrogen receptor alpha in
MCF7 breast cancer cells. Endocrine 22(3):275–284.
Walker BE, Haven MI. 1997. Intensity of multigenerational car-
cinogenesis from diethylstilbestrol in mice. Carcinogenesis
18(4):791–793.
Weaver ICG, Cervoni N, Champagne FA, D’Alessio AC, Sharma S,
Seckl JR, et al. 2004. Epigenetic programming by maternal
behavior. Nat Neurosci 7(8):847–854.
Weaver ICG, Champagne FA, Brown SE, Dymov S, Sharma S,
Meaney MJ, et al. 2005. Reversal of maternal programming
of stress responses in adult offspring through methyl
supplementation: altering epigenetic marking later in life.
J Neurosci 25(47):11045–11054.
Wilks A, Seldran M, Jost JP. 1984. An estrogen-dependent
demethylation at the 5’ end of the chicken vitellogenin gene
is independent of DNA synthesis. Nucleic Acids Res 12(2):
1163–1177.
Wu GY, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. 2004.
Maternal nutrition and fetal development. J Nutr 134(9):
2169–2172.
Wu Q, Ohsako S, Ishimura R, Suzuki JS, Tohyama C. 2004.
Exposure of mouse preimplantation embryos to 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) alters the methylation status
of imprinted genes H19 and Igf2. Biol Reprod 70(6):1790–1797.
Xu Q, Liu HQ, Zhang L, Liu NN. 2005. Resistance in the mosquito,
Culex quinque-fasciatus, and possible mechanisms for
resistance. Pest Manag Sci 61(11):1096–1102.
Yang JM, Arnush M, Chen QY, Wu XD, Pang B, Jiang XZ. 2003.
Cadmium-induced damage to primary cultures of rat Leydig
cells. Reprod Toxicol 17(5):553–560.
Yu W, Sipowicz MA, Haines DC, Birely L, Diwan BA, Riggs CW,
et al. 1999. Preconception urethane or chromium(III) treat-
ment of male mice: multiple neoplastic and non-neoplastic
changes in offspring. Toxicol Appl Pharmacol 158(2):161–176.